Alice Klein, Author at New Scientist Science news and science articles from New Scientist Mon, 13 Jul 2026 11:19:04 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.1 242057827 Four children with terminal brain cancer saved by new cell therapy /article/2533638-four-children-with-terminal-brain-cancer-saved-by-new-cell-therapy/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Mon, 13 Jul 2026 11:00:28 +0000 /?post_type=article&p=2533638 2533638 Beetroot juice is trending – its benefits go beyond the hype /article/2532642-beetroot-juice-is-trending-its-benefits-go-beyond-the-hype/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Mon, 06 Jul 2026 08:00:36 +0000 /?post_type=article&p=2532642 2532642 Unapproved gene therapy for boosting longevity is set to go on sale /article/2530933-unapproved-gene-therapy-for-boosting-longevity-is-set-to-go-on-sale/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Tue, 23 Jun 2026 11:14:33 +0000 /?post_type=article&p=2530933 2530933 Chilling the body with drugs could limit brain damage from stroke /article/2530657-chilling-the-body-with-drugs-could-limit-brain-damage-from-stroke/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Wed, 17 Jun 2026 18:00:21 +0000 /?post_type=article&p=2530657
Stroke can cause lasting damage, but quickly cooling down the body could mitigate these effects
BSIP SA/Alamy

A combination of two drugs used to treat hay fever and psychosis cooled down the core body temperature of mice and monkeys, reducing brain damage after a stroke. These medications have also undergone preliminary testing in people, and will now be evaluated in a follow-up clinical trial.

Researchers have spent decades investigating ways to chill people’s brains after they have a stroke to try to limit the damage. The idea is to freeze brain cells in a hibernation-like state so they don’t need as much oxygen and glucose when a stroke cuts off their blood supply. If brain cells can be kept alive until blood flow is restored, for example, by removing a clot, a patient may be spared from extensive brain damage and related speech and movement problems.

Unfortunately, the physical cooling strategies that have been looked at so far – including cooling blankets, ice packs and helmets – haven’t worked well. This is because they cause intense discomfort and uncontrollable shivering, says at the University of Newcastle in Australia, who wasn’t involved in the study.

Shivering is one method the body uses to “fight the induction of hypothermia”, making it hard to get body temperature down low enough, she says. “It’s great to see different cooling therapies being tested out for stroke because we know that physical cooling is just not feasible,” says Coupland.

Shuaili Xu at Capital Medical University in Beijing, China, and his colleagues administered the two drugs, promethazine and chlorpromazine, which have been known to reduce body temperature , to mice and rhesus monkeys following induced strokes.

In both animals, the drug combination led to drops in core body temperature, suppressed glucose metabolism in cells and lessened the amount of brain damage caused by the stroke. The reduced brain damage also meant the treated monkeys displayed better use of their limbs.

Next, the team conducted a clinical trial involving 32 people who had just had a stroke. Upon hospital admission, the subjects were given the promethazine and chlorpromazine combination or a placebo, in addition to standard clot-removal therapy.

The promethazine and chlorpromazine treatment only reduced the patients’ body temperature by 0.3°C (about 0.5°F) and did not reduce stroke damage. However, Xu thinks this is because the infusions were done over 12 hours, which was too slow to bring down core body temperature by a meaningful amount. “It might have led to a low blood drug concentration per unit of time,” he says.

His team is now launching another trial to see whether faster infusions over an hour produce stronger cooling effects and therapeutic benefits. “The fact that they’ve proven that it’s safe and these drugs are already used in humans for other indications means I think that it’s reasonable to proceed with further clinical trials,” says Coupland.

Promethazine and chlorpromazine are known to be relatively safe because they have been used for decades. Promethazine is a sedating antihistamine that can ease hay fever and assist sleep, while chlorpromazine is an antipsychotic drug used in the management of schizophrenia and bipolar disorder. They both act on the central nervous system to reduce core body temperature, without translating into shivering or subjective feelings of coldness.

Journal reference:

Science Translational Medicine

]]>
2530657
Sperm have been made magnetic to allow IVF inside the body /article/2530334-sperm-have-been-made-magnetic-to-allow-ivf-inside-the-body/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Mon, 15 Jun 2026 15:00:35 +0000 /?post_type=article&p=2530334 2530334 Do turmeric and curcumin have any actual health benefits? /article/2528418-do-turmeric-and-curcumin-have-any-actual-health-benefits/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Mon, 01 Jun 2026 16:14:40 +0000 /?post_type=article&p=2528418
A compound in turmeric called curcumin is sold in supplement form, but what are its benefits?
SOLDATOOFF/Shutterstock
As the temperature drops in Australia, I’ve been seeing recipes on social media for “golden milk”, a mix of turmeric, other spices and honey in warm milk. In addition to being delicious, it is meant to have medicinal qualities, thanks to a compound in turmeric called curcumin, which gives it its distinct yellow colour. Curcumin is said to have anti-inflammatory properties that are protective against cancer, arthritis, hay fever, Alzheimer’s disease, menopause symptoms and many other ailments. But is this based on solid evidence? Turmeric has been used in South Asian cooking and medicine for thousands of years, but has been exalted as a “superfood” in the West over the past couple of decades. This is largely thanks to the research of , a biochemist formerly at the University of Texas MD Anderson Cancer Center. Starting in the early 2000s, he published over 100 papers showing that curcumin reduces inflammation and kills “” of tumour cells. This sparked the popularity of the turmeric latte and curcumin supplements, and inspired a bevy of other studies. US health agencies have spent more than on curcumin research since 1990, with a large uptick following Aggarwal’s early work. The idea that a tasty, vibrant-coloured spice rooted in traditional Ayurvedic medicine might be a modern medical panacea has appeal. But a large question mark now hangs over the validity of Aggarwal’s research findings. In 2012, the Office of Research Integrity at the US Department of ÎçŇą¸ŁŔű1000ĽŻşĎ and Human Services notified MD Anderson Cancer Center about allegations by academic whistleblowers of potentially fraudulent results in (although that does not mean that the results are in fact fraudulent). Aggarwal left the cancer centre after an internal investigation and from scientific journals based on concerns about the authenticity of the results. Aggarwal’s papers, of which there are several hundred, are still regularly cited. New Scientist was unable to reach him for comment. Personally, I find it surprising that curcumin has managed to attract so much research attention because a quick look at its chemistry tells you it is unlikely to be much good as a drug. Years ago, when I did a PhD in cancer drug development, one of my lab colleagues experimented with curcumin, but found it almost impossible to work with because of its poor solubility and tendency to degrade. A 2017 in the Journal of Medicinal Chemistry, led by at the University of Minnesota, concluded that “curcumin is an unstable, reactive, nonbioavailable compound and, therefore, a highly improbable lead” for therapeutic use. Because very little curcumin dissolves in water, it isn’t easily absorbed into the blood following ingestion. Instead, most of it stays in the gut and is excreted in faeces. A study published by Dutch researchers last year found that who took curcumin supplements, even high doses of “enhanced” formulations meant to boost absorption with piperidine from black pepper or nanoparticle delivery systems. The concentrations detected in the volunteers’ blood were more than 100 times lower than those that have shown activity against cancer cells in a dish. This probably explains why curcumin has failed to show convincing benefits in any rigorous clinical trials of people with , or other conditions. According to Nelson and her colleagues, curcumin is “a missile that continually blows up on the launch pad, never reaching the atmosphere or its intended target(s).”

Too much of a good thing

Concerns have also been raised about the safety of turmeric and curcumin supplements. Turmeric is safe to eat in curries and other meals because small amounts are mixed with other ingredients. Moreover, only around 5 per cent of the dry weight of turmeric is curcumin. But supplements containing concentrated curcumin, especially enhanced formulations, are digested differently and can cause liver problems in some individuals. According to the US National Institute of Diabetes and Digestive and Kidney Diseases, “turmeric appears to have become the in the United States”, with most cases “attributed to highly bioavailable forms of curcumin” like the enhanced formulations the Dutch researchers studied. Symptoms of these liver injuries include yellowing of the skin, dark urine and nausea. They usually resolve once a person stops taking the supplement, but a of liver failure.
Scanning electron micrograph of a hepatic stellate cell, which forms scar tissue in response to liver damage
STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY
Another concern is that turmeric products are sometimes adulterated with harmful substances. In the US, for instance, more than a dozen brands of ground turmeric spice were voluntarily recalled between 2011 and 2016 after they were , which was added to enhance the spice’s yellow colour. Some children who regularly ate food spiced with these products were found to have . In Norway and Sweden, meanwhile, a turmeric supplement that caused liver problems and some deaths was found to be . I had a go at brewing up some golden milk, hoping the turmeric in my cupboard was lead-free, and can confirm that it is deeply comforting to the soul, if nothing else. I think I will make it a winter staple, but with the recognition that its magic lies in turmeric’s unique flavour, rather than in any miracle health benefits. Aggarwal and his colleagues once in the journal of the American Association of Pharmaceutical Scientists that curcumin’s efficacy may seem “too good to be true”. He was certainly right about that. ]]>
2528418
Pancreatic cancer halted by virus injection in three patients /article/2528235-pancreatic-cancer-halted-by-virus-injection-in-three-patients/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Fri, 29 May 2026 08:00:56 +0000 /?post_type=article&p=2528235 2528235 Australia is battling its largest diphtheria outbreak in living memory /article/2527469-australia-is-battling-its-largest-diphtheria-outbreak-in-living-memory/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Fri, 22 May 2026 11:00:25 +0000 /?post_type=article&p=2527469 2527469 Women’s better memories may delay Alzheimer’s diagnosis by years /article/2526378-womens-better-memories-may-delay-alzheimers-diagnosis-by-years/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Thu, 21 May 2026 11:00:38 +0000 /?post_type=article&p=2526378 2526378 Women’s body temperature rises from age 18 to 42 but we don’t know why /article/2527312-womens-body-temperature-rises-from-age-18-to-42-but-we-dont-know-why/?utm_campaign=RSS|NSNS&utm_content=currents&utm_medium=RSS&utm_source=NSNS Wed, 20 May 2026 18:00:46 +0000 /?post_type=article&p=2527312
Hot flushes are associated with the menopause, but women actually get progressively hotter from the start of adulthood to midlife
Dmitry Marchenko/Alamy

Resting body temperature rises a little bit each year in women from the age of 18 to 42, for reasons that are still being figured out. The finding opens up the possibility of using temperature-sensing wearables to track ageing and detect perimenopause or potential health problems.

“We think there is a lot of information about health in the temperature signal,” says  at SRI International, a research institute headquartered in California. “We hope this facilitates investigations to identify novel markers of conditions – it may be an untapped resource of information about our health.”

Gombert-Labedens and her colleagues analysed data from a  that asked more than 750 women aged 18 to 42 to measure their oral or rectal temperature with a thermometer every day when they first woke up.

The readings showed that, on average, body temperature was lower during the first half of the participants’ menstrual cycles and higher during the second half, after ovulation occurred. Many fertility-tracking apps use this temperature jump to predict a user’s fertile window.

Gombert-Labedens and her colleagues re-examined the data in more detail to investigate the effect of age on temperature across different stages of the menstrual cycle. They found that each year from age 18 to 42, the participants became a fraction warmer, on average. As a result, those aged 35 and older tracked about 0.05°C hotter than the younger subjects across both halves of the menstrual cycle.

This is consistent with the team’s previous research that found that finger skin temperature, measured continuously by a smart ring, was  than in those aged 18 to 35.

Further research is required to explain why this temperature increase occurs, but it probably has something to do with hormonal changes, especially towards the end of the reproductive years, says Gombert-Labedens. When perimenopause begins, temperature can increase suddenly and cause hot flushes and night sweats, but it’s unclear whether this is linked to the same mechanisms, she says.

The study only included women who did not use hormonal contraception and did not have hormonal conditions such as PMOS (polyendocrine metabolic ovarian syndrome, previously known as PCOS), so we don’t yet know how these factors might affect body temperature over time.

Other research has found that after menopause, body temperature in women tends to  and become similar to that of men.

The higher temperature around midlife may explain why anecdotally, some women at this age say they don’t feel the cold as much as they used to, says Gombert-Labedens. “We speculate that the higher temperature in midlife women could influence their perception and reaction to environmental temperature,” she says.

As smart rings and other temperature-sensing wearables become more popular, it may be possible to identify patterns or deviations in individuals’ temperature trends that signal the approach of menopause, provide an estimate of their rate of biological ageing or detect early signs of ovarian cancer or other conidtions, says Gombert-Labedens.

Journal reference:

Science Translational Medicine

]]>
2527312